BackgroundSystematic reviews (SR) provide the highest level of evidence in research. Medical students are encouraged to learn how to conduct SR, yet barriers to engaging in these reviews need to be id
Given the need to improve the efficacy of standard-of-care immunotherapy (anti-CTLA-4 + anti-PD-1) in human malignant pleural mesothelioma (hMPM), we thoroughly characterized the immunobiology of the
Notes:* Denominator is number of reviews with a primary outcome (n = 274), † denominator is published reviews (n = 301), ‡ denominator is number of reviews with funding (n = 216).
